Calidi Biotherapeutics announced the appointment of Mark Gilbert, MD, scientist emeritus at the National Institutes of Health, to its Medical Advisory Board. This addition increases the board’s membership to eight. Dr. Gilbert most recently served as the Chief of the Neuro-Oncology Branch at NIH from 2014 to 2024.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLDI:
- Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board
- Upcoming Stock Splits This Week (July 15 to July 19) – Stay Invested
- Calidi Biotherapeutics Announces 1-for-10 Reverse Stock Split
- Calidi to effect 1-for-10 reverse stock split
- Calidi initiated with a Buy at Ladenburg